2 results
Approved WMOPending
The objectives of this study are to determine the safety and efficacy of IW-9179administered to patients with functional dyspepsia (FD), with and without concomitant protonpump inhibitor (PPI) administration.
Approved WMOWill not start
To assess the safety and reactogenicity of HB-101.To assess the immunogenicity of HB-101.